We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

125 hedge funds and large institutions have $621M invested in Vanda Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 42

2.42% more ownership

Funds ownership: 88.55% → 90.97% (+2.4%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less funds holding

Funds holding: 137 → 125 (-12)

13% less capital invested

Capital invested by funds: $711M → $621M (-$89.8M)

48% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 25

92% less call options, than puts

Call options by funds: $768K | Put options by funds: $9.36M

Holders
125
Holders Change
-12
Holders Change %
-8.76%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
49
Reduced
42
Closed
25
Calls
$768K
Puts
$9.36M
Net Calls
-$8.59M
Net Calls Change
-$13.9M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$17M
2
SCM
Stonepine Capital Management
Oregon
+$8.68M
3
State Street
State Street
Massachusetts
+$7.22M
4
ACA
Avoro Capital Advisors
New York
+$6.24M
5
Macquarie Group
Macquarie Group
Australia
+$5.62M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$9.78M
2
Invesco
Invesco
Georgia
-$7.34M
3
Millennium Management
Millennium Management
New York
-$4.65M
4
RCM
RA Capital Management
Massachusetts
-$4.37M
5
Principal Financial Group
Principal Financial Group
Iowa
-$3.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
51
Foundry Partners
Minnesota
$1.17M -$910K -61,286 -44%
CCMU
52
Cheyne Capital Management (UK)
United Kingdom
$1.13M – – –
DCM
53
Dupont Capital Management
Delaware
$1.12M – – –
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$1.09M -$43.2K -2,910 -4%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$1.06M -$11.9K -800 -1%
Swiss National Bank
56
Swiss National Bank
Switzerland
$1.06M – – –
VEA
57
Virtus ETF Advisers
New York
$1.03M -$103K -6,920 -9%
VFA
58
Virtus Fund Advisers
Connecticut
$1.03M +$1.01M +67,813 New
UBS Group
59
UBS Group
Switzerland
$947K -$991K -66,748 -52%
California Public Employees Retirement System
60
California Public Employees Retirement System
California
$930K – – –
SO
61
STRS Ohio
Ohio
$854K +$180K +12,100 +27%
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$811K – – –
HCM
63
Highbridge Capital Management
New York
$793K +$90.1K +6,068 +13%
WMSA
64
Weiss Multi-Strategy Advisers
New York
$760K -$74.2K -5,000 -9%
CAM
65
ClariVest Asset Management
California
$698K +$594K +40,000 +667%
HI
66
HBK Investments
Texas
$690K -$300K -20,200 -31%
SAMH
67
Shanda Asset Management Holdings
British Virgin Islands
$681K +$665K +44,787 New
Squarepoint
68
Squarepoint
New York
$678K +$14.1K +947 +2%
LCM
69
Landscape Capital Management
New Jersey
$672K +$656K +44,190 New
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$657K -$121K -8,125 -16%
CS
71
Credit Suisse
Switzerland
$628K -$183K -12,349 -23%
Los Angeles Capital Management
72
Los Angeles Capital Management
California
$571K +$328K +22,105 +143%
PPA
73
Parametric Portfolio Associates
Washington
$551K -$435K -29,335 -45%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$519K +$5.77K +389 +1%
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$517K – – –
1 2
3
4 5

VNDA Hedge Fund Activity: Q4 2017 in Review

125 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q4 2017, worth a combined $621M — down 13% from $711M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of VNDA and 13 opened new positions — a net loss of 12 holders — while 42 trimmed existing stakes and 49 added.

The largest buyer was Armistice Capital, adding an estimated $17M. The largest seller was Citadel Advisors, cutting an estimated $9.78M.

  • 125 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q4 2017, down from 137 in Q3 2017.
  • Funds reported $621M of Vanda Pharmaceuticals stock for Q4 2017, down 13% quarter-over-quarter.
  • 13 funds opened new Vanda Pharmaceuticals positions in Q4 2017 and 25 closed out, a net change of -12 holders.
  • The largest Vanda Pharmaceuticals buyer in Q4 2017 was Armistice Capital, an estimated $17M added.
  • The largest Vanda Pharmaceuticals seller in Q4 2017 was Citadel Advisors, an estimated $9.78M sold.

Based on aggregated 13F filings for Q4 2017.